Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Brian Mueller. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Brian Mueller har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:BMRN / BioMarin Pharmaceutical Inc. | EVP, Chief Financial Officer | 99 781 |
US:ANTH / Anthera Pharmaceuticals, Inc. | Director | 84 705 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Brian Mueller. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp ANTH / Anthera Pharmaceuticals, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i ANTH / Anthera Pharmaceuticals, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel ANTH / Anthera Pharmaceuticals, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i ANTH / Anthera Pharmaceuticals, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til min |
Pris ved min |
Maks tap unngått ($) |
Maks tap unngått (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Brian Mueller som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 16 640 | 99 781 | 20,01 | ||||
2025-03-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −18 497 | 83 141 | −18,20 | 69,44 | −1 284 432 | 5 773 311 | |
2025-02-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 367 | 101 638 | 10,15 | ||||
2025-02-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 660 | 92 271 | 11,69 | ||||
2025-02-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 040 | 82 611 | 15,43 | ||||
2024-07-01 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −588 | 71 571 | −0,81 | 82,33 | −48 410 | 5 892 440 | |
2024-05-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 72 159 | −6,48 | 75,19 | −375 950 | 5 425 635 |
2024-05-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 77 159 | 6,93 | 63,10 | 315 500 | 4 868 733 |
2024-05-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 300 | 72 159 | 0,42 | 68,65 | 20 594 | 4 953 427 | |
2024-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −20 789 | 71 859 | −22,44 | 83,87 | −1 743 573 | 6 026 814 | |
2024-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 400 | 92 648 | 14,03 | ||||
2024-02-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 6 103 | 81 248 | 8,12 | ||||
2024-02-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 8 802 | 75 145 | 13,27 | ||||
2024-02-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 20 220 | 66 343 | 43,84 | ||||
2024-02-12 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 318 | 46 123 | 0,69 | 66,88 | 21 267 | 3 084 614 | |
2023-06-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −576 | 45 805 | −1,24 | 88,93 | −51 224 | 4 073 439 | |
2023-06-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −4 602 | 46 381 | −9,03 | 88,93 | −409 256 | 4 124 662 | |
2023-06-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −4 602 | 46 381 | −9,03 | 88,93 | −409 256 | 4 124 662 | |
2023-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 973 | 55 585 | −6,67 | 93,41 | −371 118 | 5 192 195 | |
2023-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 708 | 59 558 | −4,35 | 87,74 | −237 600 | 5 225 619 | |
2023-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 630 | 62 266 | 18,30 | ||||
2023-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 1 250 | 52 636 | 2,43 | ||||
2023-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 10 980 | 51 386 | 27,17 | ||||
2023-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 12 660 | 40 406 | 45,63 | ||||
2023-01-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 500 | 27 746 | −8,27 | 114,50 | −286 250 | 3 176 917 |
2023-01-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 500 | 30 246 | 9,01 | 63,10 | 157 750 | 1 908 523 |
2022-12-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 500 | 27 746 | −8,27 | 107,50 | −268 750 | 2 982 695 |
2022-12-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 500 | 30 246 | 9,01 | 63,10 | 157 750 | 1 908 523 |
2022-12-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 761 | 27 746 | −11,94 | 104,50 | −393 024 | 2 899 457 |
2022-12-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 3 761 | 31 507 | 13,56 | 67,81 | 255 033 | 2 136 490 |
2022-12-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 139 | 27 746 | −7,16 | 104,50 | −223 526 | 2 899 457 |
2022-12-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 139 | 29 885 | 7,71 | 67,81 | 145 046 | 2 026 502 |
2022-12-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 101 | 27 746 | −3,82 | 104,50 | −115 054 | 2 899 457 |
2022-11-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 500 | 28 847 | −10,82 | 99,50 | −348 250 | 2 870 276 |
2022-11-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 3 500 | 32 347 | 12,13 | 67,81 | 237 335 | 2 193 450 |
2022-11-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −945 | 28 847 | −3,17 | 99,50 | −94 028 | 2 870 276 |
2022-11-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −934 | 29 792 | −3,04 | 95,09 | −88 814 | 2 832 921 |
2022-08-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 500 | 30 726 | −10,23 | 94,50 | −330 750 | 2 903 607 |
2022-08-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 3 500 | 34 226 | 11,39 | 67,81 | 237 335 | 2 320 865 |
2022-07-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −7 337 | 30 726 | −19,28 | 89,50 | −656 662 | 2 749 977 |
2022-07-01 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −576 | 38 063 | −1,49 | 83,92 | −48 338 | 3 194 247 | |
2022-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −9 762 | 0 | −100,00 | |||
2022-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −2 038 | 0 | −100,00 | |||
2022-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −9 762 | 38 639 | −20,17 | 84,50 | −824 889 | 3 264 996 |
2022-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 9 762 | 48 401 | 25,26 | 37,46 | 365 685 | 1 813 101 |
2022-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 038 | 38 639 | −5,01 | 84,50 | −172 211 | 3 264 996 |
2022-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 038 | 40 677 | 5,27 | 37,46 | 76 343 | 1 523 760 |
2022-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 340 | 38 639 | 0,89 | 62,41 | 21 218 | 2 411 344 | |
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −582 | 38 299 | −1,50 | 80,72 | −46 979 | 3 091 495 | |
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 26 520 | 26 520 | |||||
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 868 | 38 881 | −4,58 | 78,27 | −146 208 | 3 043 216 | |
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 040 | 40 749 | 37,16 | ||||
2022-02-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 072 | 29 709 | −3,48 | 87,77 | −94 089 | 2 607 559 | |
2021-06-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −576 | 30 781 | −1,84 | 83,46 | −48 073 | 2 568 982 | |
2021-05-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −6 709 | 0 | −100,00 | |||
2021-05-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −6 709 | 31 357 | −17,62 | 79,50 | −533 366 | 2 492 882 |
2021-05-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 6 709 | 38 066 | 21,40 | 28,23 | 189 395 | 1 074 603 |
2021-05-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 341 | 31 357 | 1,10 | 62,41 | 21 281 | 1 956 896 | |
2021-04-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 692 | 31 016 | −15,51 | 76,30 | −434 300 | 2 366 521 |
2021-03-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −516 | 36 708 | −1,39 | 78,52 | −40 516 | 2 882 312 | |
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −582 | 37 224 | −1,54 | 77,21 | −44 936 | 2 874 065 | |
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 24 890 | 24 890 | |||||
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −994 | 37 806 | −2,56 | 78,39 | −77 920 | 2 963 612 | |
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 10 110 | 38 800 | 35,24 | ||||
2021-02-12 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 17 | 29 761 | 0,06 | 62,59 | 1 064 | 1 862 622 | |
2021-02-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 071 | 28 673 | −3,60 | 82,82 | −88 700 | 2 374 698 | |
2020-06-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 13 230 | 13 230 | |||||
2020-06-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 4 640 | 29 744 | 18,48 | ||||
2020-06-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 323 | 25 104 | 1,30 | 62,59 | 20 215 | 1 571 159 | |
2020-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −414 | 24 781 | −1,64 | 73,05 | −30 243 | 1 810 252 | |
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 9 600 | 9 600 | |||||
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 6 730 | 25 195 | 36,45 | ||||
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 303 | 18 465 | −6,59 | 84,50 | −110 104 | 1 560 292 | |
2020-02-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 5 800 | 19 768 | 41,52 | ||||
2020-02-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 | 13 968 | 0,06 | 62,23 | 560 | 869 215 | |
2019-06-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 299 | 13 959 | 2,19 | 68,78 | 20 566 | 960 128 | |
2019-04-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 953 | 13 660 | −17,78 | 94,00 | −277 582 | 1 284 040 |
2019-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −415 | 16 613 | −2,44 | 88,05 | −36 541 | 1 462 775 | |
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 9 650 | 9 650 | |||||
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 5 780 | 17 028 | 51,39 | ||||
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 149 | 11 248 | −9,27 | 94,53 | −108 615 | 1 063 273 | |
2018-12-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 22 | 12 397 | 0,18 | 68,78 | 1 513 | 852 690 | |
2018-08-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −782 | 6 709 | −10,44 | |||
2018-08-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −1 718 | 0 | −100,00 | |||
2018-08-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 500 | 12 375 | −16,81 | 104,50 | −261 250 | 1 293 188 |
2018-08-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 782 | 14 875 | 5,55 | 28,23 | 22 076 | 419 921 |
2018-08-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 1 718 | 14 093 | 13,88 | 28,23 | 48 499 | 397 845 |
2018-06-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −2 491 | 1 718 | −59,18 | |||
2018-06-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 491 | 12 375 | −16,76 | 99,50 | −247 854 | 1 231 312 |
2018-06-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 491 | 14 866 | 20,13 | 28,23 | 70 321 | 419 667 |
2018-06-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −654 | 12 375 | −5,02 | 99,50 | −65 073 | 1 231 312 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 021 | 13 029 | −13,43 | 94,50 | −190 984 | 1 231 240 |
2018-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −346 | 15 050 | −2,25 | 92,07 | −31 856 | 1 385 654 | |
2018-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 450 | 15 396 | −13,73 | 89,50 | −219 275 | 1 377 942 |
2018-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 287 | 17 846 | 1,63 | 68,78 | 19 740 | 1 227 484 | |
2018-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −414 | 17 559 | −2,30 | 81,36 | −33 683 | 1 428 600 | |
2018-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −346 | 12 263 | −2,74 | 84,10 | −29 099 | 1 031 318 | |
2018-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 9 120 | 9 120 | |||||
2018-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 5 710 | 17 973 | 46,56 | ||||
2018-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −309 | 12 609 | −2,39 | 83,57 | −25 823 | 1 053 734 | |
2018-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 33 | 12 918 | 0,26 | 69,78 | 2 303 | 901 379 | |
2018-01-09 |
|
4 | ANTH |
Anthera Pharmaceuticals Inc
Stock Option (right to buy) |
A - Award | 84 705 | 84 705 | |||||
2018-01-09 |
|
4 | ANTH |
Anthera Pharmaceuticals Inc
Stock Option (right to buy) |
A - Award | 84 705 | 84 705 | |||||
2017-06-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −2 671 | 0 | −100,00 | |||
2017-06-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 671 | 12 885 | −17,17 | 100,00 | −267 100 | 1 288 500 |
2017-06-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 671 | 15 556 | 20,73 | 21,51 | 57 453 | 334 610 |
2017-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −376 | 12 885 | −2,84 | 90,72 | −34 111 | 1 168 927 | |
2017-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −207 | 13 261 | −1,54 | 91,50 | −18 940 | 1 213 382 | |
2017-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −2 600 | 2 671 | −49,33 | |||
2017-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 600 | 13 468 | −16,18 | 93,17 | −242 242 | 1 254 814 |
2017-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 600 | 16 068 | 19,31 | 21,51 | 55 926 | 345 623 |
2017-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −4 882 | 13 468 | −26,60 | 91,17 | −445 092 | 1 227 878 |
2017-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 270 | 18 350 | 1,49 | 70,30 | 18 982 | 1 290 078 | |
2017-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 7 740 | 7 740 | |||||
2017-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 4 790 | 18 080 | 36,04 | ||||
2017-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −376 | 13 290 | −2,75 | 90,96 | −34 201 | 1 208 858 | |
2017-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −336 | 13 666 | −2,40 | 92,50 | −31 080 | 1 264 105 | |
2017-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 62 | 14 002 | 0,44 | 68,42 | 4 242 | 958 045 | |
2016-08-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −287 | 14 260 | −1,97 | 100,00 | −28 700 | 1 426 000 |
2016-06-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −376 | 14 547 | −2,52 | 90,00 | −33 840 | 1 309 230 | |
2016-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −207 | 14 923 | −1,37 | 82,71 | −17 121 | 1 234 281 | |
2016-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −444 | 15 130 | −2,85 | 80,80 | −35 875 | 1 222 504 | |
2016-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 327 | 15 574 | 2,14 | 51,26 | 16 763 | 798 386 | |
2016-04-29 |
|
4 | ANTH |
Anthera Pharmaceuticals Inc
Stock Option (right to buy) |
A - Award | 41 379 | 41 379 | |||||
2016-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −376 | 15 247 | −2,41 | 80,34 | −30 208 | 1 224 944 | |
2016-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy) Common Stock |
A - Award | 7 000 | 7 000 | |||||
2016-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 3 570 | 15 623 | 29,62 | ||||
2016-02-12 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 127 | 12 053 | 1,06 | 51,26 | 6 510 | 617 879 | |
2015-12-24 |
|
4 | ANTH |
Anthera Pharmaceuticals Inc
Common stock |
M - Exercise | 10 000 | 10 000 | 2,89 | 28 900 | 28 900 | ||
2015-12-24 |
|
4 | ANTH |
Anthera Pharmaceuticals Inc
Stock Option (right to buy) |
M - Exercise | −10 000 | 2 500 | −80,00 | ||||
2015-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −522 | 11 926 | −4,19 | 120,46 | −62 880 | 1 436 606 | |
2015-06-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −308 | 12 448 | −2,41 | 125,57 | −38 676 | 1 563 095 | |
2015-05-22 |
|
4 | ANTH |
Anthera Pharmaceuticals Inc
Stock Option (right to buy) |
A - Award | 28 846 | 28 846 | |||||
2015-05-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −207 | 12 756 | −1,60 | 122,78 | −25 415 | 1 566 182 | |
2015-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −444 | 12 963 | −3,31 | 121,66 | −54 017 | 1 577 079 | |
2015-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 607 | 13 407 | 4,74 | 51,26 | 31 117 | 687 290 | |
2015-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 9 000 | 9 000 | |||||
2015-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 4 000 | 12 800 | 45,45 | ||||
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 10 000 | 10 000 | |||||
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 4 000 | 8 800 | 83,33 | ||||
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −7 000 | 8 800 | −44,30 | 109,46 | −766 210 | 963 235 | |
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 7 000 | 15 800 | 79,55 | 28,23 | 197 610 | 446 034 | |
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock) |
M - Exercise | −7 000 | 7 491 | −48,31 | ||||
2015-01-02 |
|
4 | ANTH |
Anthera Pharmaceuticals Inc
Stock Option (right to buy) |
A - Award | 12 500 | 12 500 | |||||
2014-12-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock) |
M - Exercise | −5 000 | 14 491 | −25,65 | ||||
2014-12-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −5 000 | 4 593 | −52,12 | 91,82 | −459 100 | 421 729 | |
2014-12-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 5 000 | 9 593 | 108,86 | 28,23 | 141 150 | 270 810 | |
2014-12-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock) |
M - Exercise | −6 429 | 0 | −100,00 | ||||
2014-12-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock) |
M - Exercise | −521 | 0 | −100,00 | ||||
2014-12-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −6 950 | 4 593 | −60,21 | 90,25 | −627 238 | 414 518 | |
2014-12-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 6 429 | 11 543 | 125,71 | 21,51 | 138 288 | 248 290 | |
2014-12-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 521 | 5 114 | 11,34 | 14,39 | 7 497 | 73 590 | |
2014-12-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −3 400 | 4 593 | −42,54 | 88,97 | −302 508 | 408 653 | |
2014-08-04 |
|
4 | ANTH |
Anthera Pharmaceuticals Inc
Stock Option (right to buy) |
A - Award | 12 500 | 12 500 | |||||
2014-08-04 |
|
4 | ANTH |
Anthera Pharmaceuticals Inc
Stock Option (right to buy) |
A - Award | 18 750 | 18 750 | |||||
2014-06-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −297 | 7 993 | −3,58 | 57,96 | −17 214 | 463 274 | |
2014-05-16 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −207 | 8 290 | −2,44 | 57,44 | −11 890 | 476 178 | |
2014-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −282 | 8 497 | −3,21 | 59,30 | −16 723 | 503 872 | |
2014-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −444 | 8 281 | −5,09 | 56,78 | −25 210 | 470 195 | |
2014-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 498 | 8 779 | 6,01 | 29,69 | 14 786 | 260 649 | |
2014-02-13 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 278 | 8 725 | 3,29 | 27,91 | 7 758 | 243 475 | |
2013-06-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −413 | 8 447 | −4,66 | 62,70 | −25 895 | 529 627 | |
2013-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 12 900 | 12 900 | |||||
2013-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 2 200 | 8 860 | 33,03 | ||||
2013-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | −3 500 | 6 429 | −35,25 | 21,51 | −75 285 | 138 288 | |
2013-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −3 500 | 6 660 | −34,45 | 70,33 | −246 155 | 468 398 | |
2013-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 3 500 | 10 160 | 52,55 | 21,51 | 75 285 | 218 542 | |
2013-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −1 447 | 6 660 | −17,85 | 70,41 | −101 890 | 468 961 | |
2013-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −479 | 8 924 | −5,09 | 65,32 | −31 288 | 582 916 | |
2013-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −817 | 8 107 | −9,16 | 67,68 | −55 295 | 548 682 | |
2013-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −4 874 | 521 | −90,34 | ||||
2013-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −7 500 | 9 403 | −44,37 | 67,11 | −503 295 | 630 998 | |
2013-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 7 500 | 16 903 | 79,76 | 21,51 | 161 325 | 363 584 | |
2013-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −7 500 | 15 200 | −33,04 | ||||
2013-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −4 457 | 9 403 | −32,16 | 65,48 | −291 858 | 615 737 | |
2013-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −4 874 | 13 860 | −26,02 | 65,35 | −318 496 | 905 696 | |
2013-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 4 874 | 18 734 | 35,17 | 14,39 | 70 137 | 269 582 | |
2013-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 581 | 13 860 | 4,38 | 23,20 | 13 482 | 321 621 | |
2013-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −3 605 | 63 595 | −5,36 | ||||
2013-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −730 | 67 200 | −1,07 | ||||
2013-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −688 | 67 930 | −1,00 | ||||
2013-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | 2 015 | 13 279 | 17,89 | 59,81 | 120 510 | 794 171 | |
2013-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −5 023 | 15 294 | −24,72 | 59,74 | −300 067 | 913 642 | |
2013-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 3 605 | 20 317 | 21,57 | 14,39 | 51 876 | 292 362 | |
2013-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 730 | 16 712 | 4,57 | 17,86 | 13 038 | 298 476 | |
2013-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 688 | 15 982 | 4,50 | 38,59 | 26 550 | 616 745 | |
2013-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
P - Purchase | 548 | 15 294 | 3,72 | 21,76 | 11 924 | 332 797 | |
2013-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −290 | 14 746 | −1,93 | 35,64 | −10 336 | 525 547 | |
2013-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −574 | 15 036 | −3,68 | 38,00 | −21 812 | 571 368 | |
2012-11-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −10 312 | 68 618 | −13,06 | |||
2012-11-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −5 500 | 78 930 | −6,51 | |||
2012-11-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −15 812 | 15 340 | −50,76 | 50,00 | −790 600 | 767 000 |
2012-11-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 312 | 31 152 | 49,48 | 38,59 | 397 940 | 1 202 156 |
2012-11-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 500 | 20 840 | 35,85 | 14,39 | 79 145 | 299 888 |
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −8 000 | 84 430 | −8,66 | |||
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 500 | 15 340 | −26,39 | 47,50 | −261 250 | 728 650 |
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 500 | 20 840 | −10,71 | 46,00 | −115 000 | 958 640 |
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 8 000 | 23 340 | 52,15 | 14,39 | 115 120 | 335 863 |
2012-07-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −2 500 | 92 430 | −2,63 | |||
2012-07-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 500 | 15 340 | −14,01 | 42,50 | −106 250 | 651 950 |
2012-07-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 500 | 17 840 | 16,30 | 14,39 | 35 975 | 256 718 |
2012-07-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −2 770 | 94 930 | −2,84 | |||
2012-07-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 770 | 15 340 | −15,30 | 40,00 | −110 800 | 613 600 |
2012-07-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 770 | 18 110 | 18,06 | 17,86 | 49 472 | 323 445 |
2012-05-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Restricted Stock Units |
M - Exercise | 150 | 2 462 | 6,49 | ||||
2012-05-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −56 | 15 340 | −0,36 | 37,98 | −2 127 | 582 613 | |
2012-05-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 150 | 15 396 | 0,98 | ||||
2012-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Restricted Stock Units |
M - Exercise | 750 | 2 612 | 40,28 | ||||
2012-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Restricted Stock Units |
M - Exercise | 812 | 3 362 | 31,84 | ||||
2012-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 750 | 15 246 | 5,17 | ||||
2012-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 812 | 14 496 | 5,93 | ||||
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −375 | 97 700 | −0,38 | ||||
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −625 | 98 075 | −0,63 | 37,50 | −23 438 | 3 677 812 | |
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −4 291 | 98 700 | −4,17 | ||||
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −417 | 102 991 | −0,40 | ||||
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −10 000 | 103 408 | −8,82 | ||||
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
A - Award | 11 800 | 113 408 | 11,61 | ||||
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −15 708 | 13 684 | −53,44 | 37,50 | −589 050 | 513 150 | |
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 375 | 29 392 | 1,29 | 17,89 | 6 709 | 525 823 | |
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 625 | 29 017 | 2,20 | 17,89 | 11 181 | 519 114 | |
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 4 291 | 28 392 | 17,80 | 17,33 | 74 363 | 492 033 | |
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 417 | 24 101 | 1,76 | 17,54 | 7 314 | 422 732 | |
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 10 000 | 23 684 | 73,08 | 11,74 | 117 400 | 278 050 | |
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 4 720 | 13 684 | 52,66 | ||||
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 664 | 8 964 | 8,00 | 19,35 | 12 846 | 173 418 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −375 | 97 650 | −0,38 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −675 | 98 025 | −0,68 | 37,50 | −25 312 | 3 675 938 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −4 291 | 98 700 | −4,17 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −417 | 102 991 | −0,40 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −10 000 | 103 408 | −8,82 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
A - Award | 11 800 | 113 408 | 11,61 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −15 708 | 13 684 | −53,44 | 37,50 | −589 050 | 513 150 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 375 | 29 392 | 1,29 | 17,89 | 6 709 | 525 823 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 625 | 29 017 | 2,20 | 17,89 | 11 181 | 519 114 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 4 291 | 28 392 | 17,80 | 17,33 | 74 363 | 492 033 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 417 | 24 101 | 1,76 | 17,54 | 7 314 | 422 732 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 10 000 | 23 684 | 73,08 | 11,74 | 117 400 | 278 050 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 4 720 | 13 684 | 52,66 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 664 | 8 964 | 8,00 | 19,35 | 12 846 | 173 418 | |
2012-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −5 000 | 101 608 | −4,69 | ||||
2012-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −5 000 | 8 300 | −37,59 | 35,06 | −175 325 | 291 040 | |
2012-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 5 000 | 13 300 | 60,24 | 11,74 | 58 700 | 156 142 | |
2012-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
P - Purchase | 964 | 8 300 | 13,14 | 13,23 | 12 750 | 109 776 |